Latanoprost/Timolol/TEV-90100

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLatanoprost/Timolol/TEV-90100

Drug Alias Name拉坦前列素/噻吗洛尔/TEV-90100Latanoprost and TEV-90100 and timololTEV-90100/latanoprost/timololLatanoprost/TEV-90100/timololTEV-90100 and latanoprost and timolol +[6]

ClassificationSmall molecules

Mechanisms of ActionProstanoid FP receptor agonistsBeta adrenergic receptors antagonists

TargetsProstanoid FP receptorBeta adrenergic receptors

Therapy Area/IndicationsGlaucoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Latanoprost Timolol

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTeva

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTeva Pharmaceutical Industries Ltd

Active IndicationsN/A

Inactive IndicationsGlaucoma

Other Information

ATC CodeN/A